New drug aims to curb brain injury after stroke
Disease control
Ongoing
This study tests a drug called Ir-CPI in 23 people who have had a bleeding stroke (intracerebral hemorrhage). The drug is given once through a vein over 48 hours, alongside standard care. The goal is to see if it is safe and can reduce swelling and further brain damage around the…
Phase: PHASE2 • Sponsor: Bioxodes S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC